Trial on removing DNA from blood in septic shock
Part of Infections clinical trials.
This trial tests a device that filters extra DNA from the blood of people with septic shock. It may help reduce inflammation and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have septic shock and need strong blood pressure medicine (like norepinephrine or adrenaline) even after fluids
- Your blood has high levels of cell-free DNA, or signs like high lactate (over 1.9) or a high SOFA score (over 7) suggesting it will be high
- You do not have uncontrolled bleeding or high risk of bleeding
- You have not had a heart attack, stroke, or blood clot in the last 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medical device (NucleoCapture) that may remove substances called circulating DNA and NETs from the blood in people with sepsis and breathing failure. The goal is to check safety and see whether it can improve blood markers and possibly outcomes.
This trial tests whether a blood-filtering device can help people with septic shock by removing harmful substances from the blood. It is for adults who have been diagnosed with septic shock within the last 24 hours.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This Phase 2 trial tests an immune-boosting cell therapy (umbilical mesenchymal stromal cells) in people with septic shock—when infection causes dangerous stress on the heart and other organs. The goal is to see if this treatment can improve outcomes compared with standard care.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.